SCHEMBL2641904

SCHEMBL2641904

CCCCCCN(CCC)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.48
CA9 Q16790 3/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
ZDHHC20 Q5W0Z9 2/20 0.45
GPR84 Q9NQS5 7/20 0.44
PPARG P37231 7/20 0.44
PPARD Q03181 7/20 0.44
PPARA Q07869 7/20 0.44
HDAC11 Q96DB2 5/20 0.44
TSHR P16473 4/20 0.44
PTPN1 P18031 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TLR2 O60603 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
FABP4 P15090 2/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
MEN1 O00255 1/20 0.44
ESR1 P03372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28618727 1.00 CA12 (0.48) CA12CA9CA1CA2ZDHHC20
SCHEMBL28111878 0.98 CA12 (0.46) CA12CA9CA1CA2ZDHHC20
SCHEMBL1416383 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL4623978 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL14763841 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL25272614 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL7652815 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL4623644 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL14763241 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20
SCHEMBL25230061 0.95 CA12 (0.52) CA12CA9CA1CA2ZDHHC20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569276-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2013-03-20 EP disclosed
WO-2011141705-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS, INC. (CA) 2011-11-17 WO disclosed